On May 6, 2024 bluebird bio, Inc. (Nasdaq: BLUE) reported that it will host a conference call to discuss first quarter 2024 results and business updates on May 9, at 8:00 a.m. ET (Press release, bluebird bio, MAY 6, 2024, View Source [SID1234642670]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To participate in the conference call, please dial +1 (800) 715-9871 (U.S. and Canada) and ask to be joined into the bluebird call or provide the Conference ID 9768329.

In addition, members of the management team will participate in the following upcoming investor conferences:

BofA Securities 2024 Health Care Conference, Thursday, May 16, at 10:00 a.m. PT (1:00 p.m. ET) in Las Vegas, NV
Goldman Sachs 45th Annual Global Healthcare Conference, Wednesday, June 12, at 11:20 a.m. ET in Miami Beach, FL
To access the live webcasts of bluebird bio’s first quarter results conference call and fireside chats, please visit the "Events & Presentations" page within the Investors & Media section of the bluebird bio website at View Source Replays of the webcasts will be available on the bluebird bio website for 90 days following the events.